NIAID Banner Logo Image

Opportunistic Infections Citation List: November 8 - November 21, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. The Acid-catalysed Synthesis of 7-Azaindoles from 3-Alkynyl-2-aminopyridines and Their Antimicrobial Activity. Leboho, T.C., S.F. van Vuuren, J.P. Michael, and C.B. de Koning. Organic & Biomolecular Chemistry, 2013. [Epub ahead of print]. PMID[24225656].

[PubMed]. OI_1108-112113.


2. Anti-Candida Activity of 1-18 Fragment of the Frog Skin Peptide Esculentin-1B: In Vitro and in Vivo Studies in a Caenorhabditis elegans Infection Model. Luca, V., M. Olivi, A. Di Grazia, C. Palleschi, D. Uccelletti, and M.L. Mangoni. Cellular and Molecular Life Sciences, 2013. [Epub ahead of print]. PMID[24221134].

[PubMed]. OI_1108-112113.


3. Antifungal Activity of Plant Defensin AFP1 in Brassica juncea involves the Recognition of the Methyl Residue in Glucosylceramide of Target Pathogen Candida albicans. Oguro, Y., H. Yamazaki, M. Takagi, and H. Takaku. Current Genetics, 2013. [Epub ahead of print]. PMID[24253293].

[PubMed]. OI_1108-112113.


4. Antimicrobial Efficacy and Wound Healing Property of a Topical Ointment Containing Nitric oxide-loaded Zeolite. Neidrauer, M., U.K. Ercan, A. Bhattacharya, J. Samuels, J. Sedlak, R. Trikha, K.A. Barbee, M.S. Weingarten, and S.G. Joshi. Journal of Medical Microbiology, 2013. [Epub ahead of print]. PMID[24196133].

[PubMed]. OI_1108-112113.


5. C. albicans Growth, Transition, Biofilm Formation, and Gene Expression Modulation by Antimicrobial Decapeptide KSL-W. Theberge, S., A. Semlali, A. Alamri, K.P. Leung, and M. Rouabhia. BMC Microbiology, 2013. 13(1): p. 246. PMID[24195531].

[PubMed]. OI_1108-112113.


6. Canine Antimicrobial Peptides are Effective against Resistant Bacteria and Yeasts. Santoro, D. and C.W. Maddox. Veterinary Dermatology, 2013. [Epub ahead of print]. PMID[24215268].

[PubMed]. OI_1108-112113.


7. Effect of Antimicrobial Agents Incorporated into Resilient Denture Relines on the C. albicans Biofilm. Bueno, M.G., V.M. Urban, G.S. Barberio, W.J. Silva, V.C. Porto, L. de Rezende Pinto, and K.H. Neppelenbroek. Oral Diseases, 2013. [Epub ahead of print]. PMID[24219354].

[PubMed]. OI_1108-112113.


8. Synthesis and Antimicrobial Activity of alpha-Aminoboronic-containing Peptidomimetics. Gozhina, O.V., J.S. Svendsen, and T. Lejon. Journal of Peptide Science, 2013. [Epub ahead of print]. PMID[24222512].

[PubMed]. OI_1108-112113.


9. Synthesis and Characterization of Some Novel Antimicrobial Thiosemicarbazone O-carboxymethyl Chitosan Derivatives. Mohamed, N.A., R.R. Mohamed, and R.S. Seoudi. International Journal of Biological Macromolecules, 2013. [Epub ahead of print]. PMID[24211430].

[PubMed]. OI_1108-112113.


10. Synthesis, Characterization, and Antimicrobial Activity of Silver(I) and Copper(II) Complexes of Phosphate Derivatives of Pyridine and Benzimidazole. Kalinowska-Lis, U., E.M. Szewczyk, L. Checinska, J.M. Wojciechowski, W.M. Wolf, and J. Ochocki. ChemMedChem, 2013. [Epub ahead of print]. PMID[24218046].

[PubMed]. OI_1108-112113.


11. An in Vitro Study of Sequential Fluconazole/Caspofungin Treatment against Candida albicans Biofilms. Sarkar, S., P. Uppuluri, C.G. Pierce, and J.L. Lopez-Ribot. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24217700].

[PubMed]. OI_1108-112113.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

12. 3D-QSAR and Cell Wall Permeability of Antitubercular Nitroimidazoles against Mycobacterium tuberculosis. Lee, S.H., M. Choi, P. Kim, and P.K. Myung. Molecules, 2013. 18(11): p. 13870-13885. PMID[24217328].

[PubMed]. OI_1108-112113.


13. Antimicrobial Polycarbonates: Investigating the Impact of Balancing Charge and Hydrophobicity Using a Same-centered Polymer Approach. Engler, A.C., J.P. Tan, Z.Y. Ong, D.J. Coady, V.W. Ng, Y.Y. Yang, and J.L. Hedrick. Biomacromolecules, 2013. [Epub ahead of print]. PMID[24228904].

[PubMed]. OI_1108-112113.


14. Azaindoles: Non-covalent DprE1 Inhibitors from Scaffold Morphing Efforts Kill Mycobacterium tuberculosis and are Efficacious in Vivo. Shirude, P.S., R. Shandil, C. Sadler, M. Naik, V. Hosagrahara, S. Hameed, V. Shinde, C. Bathula, V. Humnabadkar, N. Kumar, J. Reddy, V. Panduga, S. Sharma, A. Ambady, N. Hegde, J. Whiteaker, R.E. McLaughlin, H. Gardner, P. Madhavapeddi, V. Ramachandran, P. Kaur, A. Narayan, S. Guptha, D. Awasthy, C. Narayan, J. Mahadevaswamy, V. Kg, V. Ahuja, A. Srivastava, P. Kr, S. Bharath, R. Kale, M. Ramaiah, N.R. Choudhury, V. Sambandamurthy, S.M. Solapure, P.S. Iyer, S. Narayanan, and M. Chatterji. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24215368].

[PubMed]. OI_1108-112113.


15. Binding of Pyrazole-based Inhibitors to Mycobacterium tuberculosis Pantothenate Synthetase: Docking and MM-GB(PB)SA Analysis. Ntie-Kang, F., S. Kannan, K. Wichapong, L.C. Owono Owono, W. Sippl, and E. Megnassan. Molecular BioSystems, 2013. [Epub ahead of print]. PMID[24240974].

[PubMed]. OI_1108-112113.


16. DprE1 - from the Discovery to the Promising Tuberculosis Drug Target. Mikusova, K., V. Makarov, and J. Neres. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[24245764].

[PubMed]. OI_1108-112113.


17. Effect of Stereochemistry, Chain Length and Sequence Pattern on Antimicrobial Properties of Short Synthetic beta-Sheet Forming Peptide Amphiphiles. Ong, Z.Y., J. Cheng, Y. Huang, K. Xu, Z. Ji, W. Fan, and Y.Y. Yang. Biomaterials, 2013. [Epub ahead of print]. PMID[24211081].

[PubMed]. OI_1108-112113.


18. A High-throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-cyanopyrrole-2-carboxylic acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis. Kumar, A., A. Casey, J. Odingo, E.A. Kesicki, G. Abrahams, M. Vieth, T. Masquelin, V. Mizrahi, P.A. Hipskind, D.R. Sherman, and T. Parish. Plos One, 2013. 8(11): p. e72786. PMID[24244263].

[PubMed]. OI_1108-112113.


19. Identification of the Target Protein of Agelasine D, a Marine Sponge Diterpene Alkaloid, as an Anti-Dormant Mycobacterial Substance. Arai, M., Y. Yamano, A. Setiawan, and M. Kobayashi. ChemBioChem: A European Journal of Chemical Biology, 2013. [Epub ahead of print]. PMID[24243718].

[PubMed]. OI_1108-112113.


20. Inhibition Studies on Mycobacterium tuberculosis N-Acetylglucosamine-1-phosphate uridyltransferase (GlmU). Tran, A.T., D. Wen, N.P. West, E.N. Baker, W.J. Britton, and R.J. Payne. Organic & Biomolecular Chemistry, 2013. 11(46): p. 8113-8126. PMID[24158720].

[PubMed]. OI_1108-112113.


21. New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics. North, E.J., M. Jackson, and R.E. Lee. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[24245756].

[PubMed]. OI_1108-112113.


22. New Approaches to Tuberculosis - Novel Drugs Based on Drug Targets Related to Toll-like Receptors in Macrophages. Tomioka, H. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[24245765].

[PubMed]. OI_1108-112113.


23. New Tuberculostatic Agents Targeting Nucleic acid Biosynthesis: Drug Design Using QSAR Approaches. Bueno, R.V., R.C. Braga, N.D. Segretti, E.I. Ferreir, G.H. Trossini, and C.H. Andrade. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[24245758].

[PubMed]. OI_1108-112113.


24. Plakinamine M, a Steroidal Alkaloid from the Marine Sponge Corticium sp. Lu, Z., M. Koch, M.K. Harper, T.K. Matainaho, L.R. Barrows, R.M. Van Wagoner, and C.M. Ireland. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[24195491].

[PubMed]. OI_1108-112113.


25. Plants: A Source for New Antimycobacterial Drugs. Santhosh, R.S. and B. Suriyanarayanan. Planta Medica, 2013. [Epub ahead of print]. PMID[24218370].

[PubMed]. OI_1108-112113.


26. Potent Anti-mycobacterial Activity of the Pyridoxal isonicotinoyl hydrazone Analogue, 2-Pyridylcarboxaldehyde isonicotinoyl hydrazone: A Lipophilic Transport Vehicle for Isonicotinic acid hydrazide. Ellis, S., D.S. Kalinowski, L. Leotta, M.L. Huang, P. Jelfs, V. Sintchenko, D.R. Richardson, and J.A. Triccas. Molecular Pharmacology, 2013. [Epub ahead of print]. PMID[24243647].

[PubMed]. OI_1108-112113.


27. QSAR Based Design of New Antitubercular Compounds: Improved Isoniazi Derivatives against Multidrug-resistant TB. Martins, F., C. Ventura, S. Santos, and M. Viveiros. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[24245762].

[PubMed]. OI_1108-112113.


28. Rational Drug Design Based Synthesis of Novel Arylquinolines as Anti-tuberculosis Agents. Jain, P.P., M.S. Degani, A. Raju, M. Ray, and M.G. Rajan. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6097-6105. PMID[24095091].

[PubMed]. OI_1108-112113.


29. Structure and Activity of Lobophorins from a Turrid Mollusk-associated Streptomyces sp. Lin, Z., M. Koch, C.D. Pond, G. Mabeza, R.A. Seronay, G.P. Concepcion, L.R. Barrows, B.M. Olivera, and E.W. Schmidt. The Journal of Antibiotics, 2013. [Epub ahead of print]. PMID[24220110].

[PubMed]. OI_1108-112113.


30. Structure-and-mechanism-based Design and Discovery of Type II Mycobacterium tuberculosis Dehydroquinate dehydratase Inhibitors. Yao, Y. and L. Ze-Sheng. Current Topics in Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24236726].

[PubMed]. OI_1108-112113.


31. Synthesis and Antimicrobial Activity of alpha-Aminoboronic-containing Peptidomimetics. Gozhina, O.V., J.S. Svendsen, and T. Lejon. Journal of Peptide Science, 2013. [Epub ahead of print]. PMID[24222512].

[PubMed]. OI_1108-112113.


32. Synthesis and Antimycobacterial Activity of Isoniazid Derivatives from Renewable Fatty acids. Rodrigues, M.O., J.B. Cantos, C.R. D'Oca, K.L. Soares, T.S. Coelho, L.A. Piovesan, D. Russowsky, P.A. da Silva, and M.G. D'Oca. Bioorganic & Medicinal Chemistry, 2013. 21(22): p. 6910-6914. PMID[24103427].

[PubMed]. OI_1108-112113.


33. Synthesis and Structure-Activity Relationships of Phenyl-Substituted Coumarins with Anti-tubercular Activity That Target FadD32. Kawate, T., N. Iwase, M. Shimizu, S.A. Stanley, S. Wellington, E. Kazyanskaya, and D.T. Hung. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6052-6059. PMID[24103299].

[PubMed]. OI_1108-112113.


34. Targeting Type VII/ESX Secretion Systems for Development of Novel Antimycobacterial Drugs. Bottai, D., A. Serafini, A. Cascioferro, R. Brosch, and R. Manganelli. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[24245757].

[PubMed]. OI_1108-112113.


35. Two Rare-class Tricyclic diterpenes with Antitubercular Activity from the Caribbean Sponge Svenzea flava. Application of Vibrational Circular Dichroism Spectroscopy for Determining Absolute Configuration. Aviles, E., A.D. Rodriguez, and J. Vicente. The Journal of Organic Chemistry, 2013. 78(22): p. 11294-11301. PMID[24138557].

[PubMed]. OI_1108-112113.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

36. Antimalarial Activity of Compounds Comprising a Primary Benzene Sulfonamide Fragment. Andrews, K.T., G.M. Fisher, S.D. Sumanadasa, T. Skinner-Adams, J. Moeker, M. Lopez, and S.A. Poulsen. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6114-6117. PMID[24084158].

[PubMed]. OI_1108-112113.


37. Fast in Vitro Methods to Determine the Speed of Action and the Stage-specificity of Anti-malarials in Plasmodium falciparum. Le Manach, C., C. Scheurer, S. Sax, S. Schleiferbock, D. Gonzalez Cabrera, Y. Younis, T. Paquet, L. Street, P. Smith, X. Ding, D. Waterson, M.J. Witty, D. Leroy, K. Chibale, and S. Wittlin. Malaria Journal, 2013. 12(1): p. 424. PMID[24237770].

[PubMed]. OI_1108-112113.


38. Identification of Inhibitors of Plasmodium falciparum Gametocyte Development. Duffy, S. and V.M. Avery. Malaria Journal, 2013. 12(1): p. 408. PMID[24206914].

[PubMed]. OI_1108-112113.


39. In Vitro and in Silico Antimalarial Activity of 2-(2-Hydrazinyl)thiazole Derivatives. Makam, P., P.K. Thakur, and T. Kannan. European Journal of Pharmaceutical Sciences, 2013. [Epub ahead of print]. PMID[24231338].

[PubMed]. OI_1108-112113.


40. In Vitro and in Vivo Characterization of the Antimalarial Lead Compound SSJ-183 in Plasmodium Models. Schleiferbock, S., C. Scheurer, M. Ihara, I. Itoh, I. Bathurst, J.N. Burrows, P. Fantauzzi, J. Lotharius, S.A. Charman, J. Morizzi, D.M. Shackleford, K.L. White, R. Brun, and S. Wittlin. Drug Design, Development and Therapy, 2013. 7: p. 1377-1384. PMID[24255594].

[PubMed]. OI_1108-112113.

Citations from the ISI Web of Knowledge Listings for O.I.

41. Antimicrobial Effect of Para-alkoxyphenylcarbamic acid esters Containing Substituted N-Phenylpiperazine Moiety. Malik, I., M. Bukovsky, F. Andriamainty, and J. Galisinova. Brazilian Journal of Microbiology, 2013. 44(2): p. 457-463. ISI[000325780000017].

[WOS]. OI_1108-112113.


42. Antimicrobial Ergosteroids and Pyrrole Derivatives from Halotolerant Aspergillus flocculosus PT05-1 Cultured in a Hypersaline Medium. Zheng, J.K., Y. Wang, J.F. Wang, P.P. Liu, J. Li, and W.M. Zhu. Extremophiles, 2013. 17(6): p. 963-971. ISI[000326046200008].

[WOS]. OI_1108-112113.


43. Assay Development for Identifying Inhibitors of the Mycobacterial FadD32 Activity. Galandrin, S., V. Guillet, R.S. Rane, M. Leger, N. Radha, N. Eynard, K. Das, T.S. Balganesh, L. Mourey, M. Daffe, and H. Marrakchi. Journal of Biomolecular Screening, 2013. 18(5): p. 576-587. ISI[000326011500007].

[WOS]. OI_1108-112113.


44. Characterization, Antifungal Activity, and Cell Immobilization of a Chitinase from Serratia marcescens MO-1. Okay, S., M. Ozdal, and E.B. Kurbanoglu. Turkish Journal of Biology, 2013. 37(6): p. 639-644. ISI[000325747400001].

[WOS]. OI_1108-112113.


45. Chemical Composition and Antimicrobial Activities of Essential Oil from Artemisia integrifolia. Zhu, L., Y.J. Tian, and Y.C. Yin. Asian Journal of Chemistry, 2013. 25(14): p. 7679-7682. ISI[000325096400006].

[WOS]. OI_1108-112113.


46. Essential Oil of Common Sage (Salvia officinalis L.) from Jordan: Assessment of Safety in Mammalian Cells and Its Antifungal and Anti-inflammatory Potential. Abu-Darwish, M.S., C. Cabral, I.V. Ferreira, M.J. Goncalves, C. Cavaleiro, M.T. Cruz, T.H. Al-bdour, and L. Salgueiro. BioMed Research International, 2013. 538940: pp. 9. ISI[000325882000001].

[WOS]. OI_1108-112113.


47. In Vitro Activity of Disinfectants against Aspergillus spp. Mattei, A.S., I.M. Madrid, R. Santin, L.F.D. Schuch, and M.C.A. Meireles. Brazilian Journal of Microbiology, 2013. 44(2): p. 481-484. ISI[000325780000023].

[WOS]. OI_1108-112113.


48. An in Vitro Study on the Anti-adherence Effect of Brucea javanica and Piper Betle Extracts towards Oral Candida. Nordin, M.A.F., W. Harun, and F.A. Razak. Archives of Oral Biology, 2013. 58(10): p. 1335-1342. ISI[000325236600009].

[WOS]. OI_1108-112113.


49. Inhibitory Effect of Oxygenated Cholestan-3[beta]-ol Derivatives on the Growth of Mycobacterium tuberculosis. Schmidt, A.W., T.A. Choi, G. Theumer, S.G. Franzblau, and H.J. Knolker. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6111-6113. ISI[000325760300015].

[WOS]. OI_1108-112113.


50. Interactions between Hyaluronic acid, Lysozyme, and the Glucose Oxidase-mediated Lactoperoxidase System in Enzymatic and Candidacidal Activities. Cho, M.A., Y.Y. Kim, J.Y. Chang, and H.S. Kho. Archives of Oral Biology, 2013. 58(10): p. 1349-1356. ISI[000325236600011].

[WOS]. OI_1108-112113.


51. Microwave-assisted Preparation and Antimicrobial Activity of O-Alkylamino benzofurancarboxylates. Ostrowska, K., E. Hejchman, I. Wolska, H. Kruszewska, and D. Maciejewska. Monatshefte fur Chemie, 2013. 144(11): p. 1679-1689. ISI[000325825700013].

[WOS]. OI_1108-112113.


52. Radiation Synthesis, Characterisation and Antimicrobial Application of Novel Copolymeric Silver/Poly(2-Hydroxyethyl methacrylate/itaconic acid) Nanocomposite Hydrogels. Micic, M., T.V. Milic, M. Mitric, B. Jokic, and E. Suljovrujic. Suljovrujic. Polymer Bulletin, 2013. 70(12): p. 3347-3357. ISI[000325774400008].

[WOS]. OI_1108-112113.


53. Sydowiols A-C: Mycobacterium tuberculosis Protein Tyrosine phosphatase Inhibitors from an East China Sea Marine-derived Fungus, Aspergillus sydowii. Liu, X.R., F.H. Song, L. Ma, C.X. Chen, X. Xiao, B.A. Ren, X.T. Liu, H.Q. Dai, A.M. Piggott, Y. Av-Gay, L.X. Zhang, and R.J. Capon. Tetrahedron Letters, 2013. 54(45): p. 6081-6083. ISI[000325736300037].

[WOS]. OI_1108-112113.


54. Synthesis and Antifungal Activity of the Novel Triazole Derivatives Containing 1,2,3-Triazole Fragment. Yu, S.C., N. Wang, X.Y. Chai, B.G. Wang, H. Cui, Q.J. Zhao, Y. Zou, Q.Y. Sun, Q.G. Meng, and Q.Y. Wu. Archives of Pharmacal Research, 2013. 36(10): p. 1215-1222. ISI[000325418800008].

[WOS]. OI_1108-112113.


55. Synthesis and Antimicrobial Evaluation of Novel Substituted Pyrimidine Scaffold. Ghodasara, H.B., A.R. Trivedi, V.B. Kataria, B.G. Patel, and V.H. Shah. Medicinal Chemistry Research, 2013. 22(12): p. 6121-6128. ISI[000325827000047].

[WOS]. OI_1108-112113.


56. Synthesis of Azide Derivative and Discovery of Glyoxalase Pathway Inhibitor against Pathogenic Bacteria. Edagwa, B., Y.R. Wang, and P. Narayanasamy. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6138-6140. ISI[000325760300021].

[WOS]. OI_1108-112113.


57. Synthesis of Some New Dihydropyrimidines by Iodine as a Catalyst at Ambient Temperature and Evaluation of Their Biological Activity. Zalavadiya, P.D., R.M. Ghetiya, B.L. Dodiya, P.B. Vekariya, and H.S. Joshi. Journal of Heterocyclic Chemistry, 2013. 50(4): p. 973-978. ISI[000325924800038].

[WOS]. OI_1108-112113.


58. Synthesis, Antimicrobial, and Antioxidant Activities of N-[(5'-Substituted-2'-phenyl-1H-indol-3'-yl)methylene]-5H-dibenzo[b,f]azepine-5-carbohydrazide Derivatives. Saundane, A.R., V.T. Katkar, and A.V. Vaijinath. Journal of Chemistry, 2013. 530135: pp. 9. ISI[000325878800001].

[WOS]. OI_1108-112113.


59. Synthesis, Characterization and in Vitro Biological Evaluation of Some Novel 1,3,5-Triazine-Schiff Base Conjugates as Potential Antimycobacterial Agents. Avupati, V.R., R.P. Yejella, V.R. Parala, K.N. Killari, V.M.R. Papasani, P. Cheepurupalli, V.R. Gavalapu, and B. Boddeda. Bioorganic & Medicinal Chemistry Letters, 2013. 23(21): p. 5968-5970. ISI[000325483000044].

[WOS]. OI_1108-112113.


60. Synthesis, Evaluation of Antimicrobial Activity, and Molecular Modeling of Novel 2-((4-(2H-Benzo[d][1,2,3]triazol-2-yl)piperidin-1-yl)methyl)-5-substituted Phenyl-1,3,4-oxadiazoles. Vankadari, S.R., D. Mandala, J. Pochampalli, P. Tigulla, A. Valeru, and R. Thampu. Medicinal Chemistry Research, 2013. 22(12): p. 5912-5919. ISI[000325827000028].

[WOS]. OI_1108-112113.


61. Thermal, Kinetic, Spectroscopic Studies and Anti-microbial, Anti-tuberculosis, Anti-oxidant Properties of Clioquinol and Benzo-coumarin Derivatives Mixed Complexes with Copper Ion. Dholariya, H.R., K.S. Patel, J.C. Patel, A.K. Patel, and K.D. Patel. Medicinal Chemistry Research, 2013. 22(12): p. 5848-5860. ISI[000325827000022].

[WOS]. OI_1108-112113.


62. Unusual Transformation of Substituted-3-formylchromones to Pyrimidine Analogues: Synthesis and Antimicrobial Activities of 5-(O-Hydroxyaroyl)pyrimidines. Raj, T., N. Singh, and M.P.S. Ishar. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6093-6096. ISI[000325760300012].

[WOS]. OI_1108-112113.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022